VANCOUVER, BC – September 21, 2018
Ondine Biomedical Inc. congratulates its Medical Advisory Board member, Dr. Michael Wilson, emeritus Professor of Microbiology at University College London, on the release of his new book, The Human Microbiota in Health and Disease.
Human bodies are home to trillions of microbes (bacteria, fungi, viruses and protozoa) and our surroundings are filled with billions of trillions more. Our lives are dependent on these microbes, but we can also be seriously harmed by them if they multiply out of control, invade areas of our bodies in which they are not meant to be, or when our immune systems are compromised.
Dr. Wilson is a pioneer of antimicrobial photodynamic therapy for the treatment of oral infections, which Ondine has adapted for use in preventing and treating healthcare-associated infections and chronic sinusitis.
“What has astonished me while researching for this book is discovering the extent of the communication networks that operate in this human-microbe symbiosis,” says Dr. Wilson. “Signalling pathways exist between members of the same species, as well as between different species, within a microbial community and also between these microbes and their mammalian hosts. The complexity is astonishing, and we are only just beginning to listen in to these multiple conversations – we have so much more to learn.”
The Human Microbiota in Health and Disease: An Ecological and Community-Based Approach describes the nature of the various communities inhabiting humans as well as the important roles they play in human health and disease. It discusses techniques used to determine microbial community composition and features a chapter devoted to the many factors that underlie this mammalian–microbe symbiosis. Uniquely, the book adopts an ecological approach to examining the microbial community’s composition at a particular body site and why certain factors can shift a community from a eubiotic to a dysbiotic state.The Human Microbiota in Health and Disease is available for purchase online here.
Ondine Biomedical Inc. is dedicated to the development of non-antibiotic anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections. Ondine’s platform technology is called Photodisinfection, a patented light activated technology that provides rapid antimicrobial efficacy without encouraging antibiotic resistance.
Dr. Michael Wilson is emeritus Professor of Microbiology at University College London (UCL), where he has conducted research and taught Bachelor and Masters courses in Microbiology since 1983. His main research interests are the indigenous microbiota of humans, biofilms, bacterial pathogenesis, antibiotic resistance and the development of new antimicrobial strategies. In recognition of his research achievements, he was awarded a DSc degree in 1999 by the National University of Ireland and in 2011 was appointed Chevalier dans l’Ordre des Palmes Académiques by the French Minister of National Education. He has a great interest in translational research and has applied for 13 patents for inventions in the fields of light-activated antimicrobial agents and water purification for which he has received several awards. He has published 334 peer-reviewed scientific papers and 11 books, one of which (“Bacteriology of Humans: an ecological perspective”) was awarded first prize in the Royal Society of Medicine and Society of Authors Medical Book Awards in 2008.